Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Healthcare Bioconvergence Market Size Worth USD 188.79 Billion by 2032 at 5.33% CAGR – Report by Market Research Future (MRFR)

Published

on

<!– Name:DistributionId Value:8845938 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value: –> <!– Name:CustomerId Value:1259337 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:6edd3237-60ca-418a-89a8-ae425e5b7b83 –>

New York, USA, May 24, 2023 (GLOBE NEWSWIRE) — According to a Comprehensive Research Report by Market Research Future (MRFR), “Healthcare Bioconvergence Market Information by Applications, by Technology And by Region – Forecast till 2032”, the market is poised to reach USD 188.79 billion by 2032, registering a 5.33% CAGR throughout the assessment period (2023-2032).

The global healthcare bioconvergence market is likely to demonstrate notable revenue growth during the next few years. Growing investments in technology development would drive the market. The market will likely benefit from the rising prevalence of chronic diseases and rapid technology upgrades in AI, machine learning, and Blockchain technology in the healthcare sector. Additionally, government initiatives to boost healthcare infrastructure, extensive funding for R&D, and rising investments from key players are projected to drive market growth during the forecast period.

Bioconvergence is a relatively recent development in the healthcare and biotech industries. It involves the integration of two or more technologies with the objective of offering advanced and improved services or products. The healthcare bioconvergence market is driven by the need to provide an improved quality of care to patients, reduce the cost of healthcare, increase efficiency, and develop innovative solutions and treatments. 

Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/11598

The goal of healthcare bioconvergence is to make healthcare more personalized, efficient, and cost-effective. It combines the strengths of different healthcare technologies and services, allowing them to work together more efficiently and effectively. This technology is being utilized to improve patient care, increase operational efficiency, and provide more personalized patient care.

Report Scope:

Report Attribute Details
Market Size in 2032 USD 188.79 Billion
CAGR 5.33%
Base Year 2022
Forecast Period 2023-2032
Historical Data 2021
Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered By Technology And Applications
Geographies Covered North America, Europe, Asia-Pacific, and Rest of the World (RoW)

Healthcare Bioconvergence Market Competitive Analysis

The highly competitive healthcare bioconvergence market appears fragmented due to the strong presence of industry players holding substantial market shares. These players are continually focusing on new product development initiatives and geographical expansion, allowing the market to witness relentless innovations and new product development, eventually resulting in intense competition among healthcare bioconvergence service providers. 

Well-established players incorporate strategic approaches, such as acquisitions, collaborations, partnerships, expansions, and product & technology launches, to gain a larger market share. These strategies help them develop new healthcare bioconvergence technologies & services and, thus, gain a competitive advantage in the market. 

For instance, on Jan. 26, 2023, The Ministry of Finance, Israel, announced an investment of over NIS 900 million to sponsor the development of AI, bio-convergence. Investment grants will be distributed among academic institutions and businesses, channeled to the development of artificial intelligence and bio-convergence, a convergence between biology, computing, and engineering in healthcare. 

The key players in the global healthcare bioconvergence market are IBM, Apple Health Solutions, Medtronic, GE Healthcare, Oracle Health Science, Johnson & Johnson, McKesson Corporation, and Microsoft Corporation, among others. 

Healthcare Bioconvergence Market Trends

The healthcare bioconvergence market is witnessing several trends, such as increasing demand for personalized care, rising adoption of AI and genomic sequencing, and the emergence of ethical concerns around the usage of healthcare bioconvergence. Personalized care is gaining traction as the key demand in the market. The increasing demand for personalized care has led to the development of various products and services tailored to meet individual patient needs.

The industry trends in the global healthcare bioconvergence market include the emergence of ethical concerns regarding the usage of healthcare bioconvergence, the increasing demand for personalized care, and the increasing adoption of AI and genomic sequencing. Additionally, the rise of telemedicine and the use of wearables in healthcare are also estimated to drive the growth of the market.

Browse In-depth Market Research Report (115 Pages) on Healthcare Bioconvergence: https://www.marketresearchfuture.com/reports/healthcare-bioconvergence-market-11598

The increasing demand for personalized care, advances in the healthcare sector, and government initiatives to boost healthcare infrastructure substantiate the healthcare bioconvergence market revenues. Additionally, rising investments from key players, the emergence of ethical concerns about the usage of healthcare bioconvergence, and the increasing adoption of AI and genomic sequencing are also anticipated to drive the market’s growth.

AI and genomic sequencing are helping to provide personalized care as they are responsible for tracking, sorting, and analyzing patient data. AI and genomic sequencing have fully transformed the healthcare industry, allowing physicians to gain a better understanding of their patients’ biology and treatment options. AI is also used in drug discovery, clinical decision support, and diagnostics, while genomic sequencing is used in personalized therapies and diagnostics.

Healthcare Bioconvergence Market Segmentation

The healthcare bioconvergence market is segmented on the basis of application, technology, and region. The application segment is divided into healthcare providers, pharmaceutical and biotechnology companies, healthcare IT companies, and pricing and reimbursement offices. The technology segment is classified into enterprise healthcare solutions, artificial intelligence, and precision medicine.

Buy Now: https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=11598

Healthcare Bioconvergence Market Regional Analysis

North America dominates the global healthcare bioconvergence market, followed by Europe and Asia-Pacific. The U.S. dominated the North American healthcare bioconvergence market in 2018 and is expected to continue leading over the forecast period. The increasing demand for personalized care and the rising adoption of AI and genomic sequencing create vast healthcare bioconvergence market opportunities.

The healthcare bioconvergence market in the Asia-Pacific region perceives the highest growth rate. This is due to the increasing investments from key players, rising healthcare expenditure in the region, and the emergence of data analytics and predictive technologies in the healthcare sector. 

Discover more research Reports on Healthcare Industry by Market Research Future:

Healthcare eDiscovery Market Research: By Deployment (On-Premise System and Cloud System), Application (Audit Trail Via Metadata, Communication, Ehr-Hosting), End-Users (Healthcare It Companies, Hospitals, Clinics, Pharmacy) – Forecast till 2030

Healthcare Big Data Analytics Market Research Report Information By Type (Descriptive Analytics, Predictive Analytics, Prescriptive Analytics, and Others), By Product (Hardware, Software, and Service), By Application (Financial Analytics, Clinical Analytics, Operational, Administrative Analytics, Population Health Analytics, and Others), By Mode of Delivery (On-Premise Model, and Cloud-Based Model), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030

Healthcare IT Market Research Report Information By Products and Services (Healthcare Provider Solutions, Healthcare Payer Solutions), By Component (Services, Software), By End-User (Healthcare Providers, Healthcare Payers, Research Centers), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Follow Us: LinkedIn | Twitter


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Courageous Whistleblowers Reclaim Derogatory Terms As Data Shows 80% of Financial Professionals Stay Silent on Suspected Internal Fraud, Fearing Retaliation

Published

on

courageous-whistleblowers-reclaim-derogatory-terms-as-data-shows-80%-of-financial-professionals-stay-silent-on-suspected-internal-fraud,-fearing-retaliation

Enron whistleblower, Sherron Watkins, alongside stars of Apple TV’s The Big Conn, Sarah Carver and Jennifer Griffith, reclaim derogatory labels for whistleblowers          Concerning new data shows more than half of financial professionals in the UK and US have spotted or suspected internal fraud in their workplaces, yet four out of five stay silent fearing retaliation          32% of professionals in finance have seen whistleblowers victimized behind their back or to their faceJACKSONVILLE, Fla., May 21, 2024 /PRNewswire/ — New data from fraud detection software company Medius shows more than half of financial professionals in the UK and US (56%) have spotted or suspected internal fraud in their workplaces yet four in five (81%) stayed silent. When asked why, 45% of professionals cited the fear of recrimination.

Whistleblowers Sherron Watkins, Sarah Carver and Jennifer Griffith have joined forces to reclaim the derogatory names they were called after reporting serious internal financial fraud.
To help empower others to come forward, the whistleblowers are reclaiming the terms “snitch”, “rat” and “traitor”.
Sherron Watkins is the former Vice President of Enron Corporation who alerted the CEO to accounting irregularities, warning the organization “‘might implode in a wave of accounting scandals.” Watkins received national acclaim for her courageous actions and TIME magazine named her along with two others as their Persons of the Year in 2002, calling them simply ‘The Whistleblowers.’
Sarah Carver and Jennifer Griffith are the stars of Apple TV’s The Big Conn after they exposed a fraud scheme of more than $550 million while employed at the Social Security Administration. In efforts to silence their disclosures, they experienced multiple acts of severe retaliation and were denied protection. Ultimately, both Carver and Griffith were forced from employment.
Concerns of repercussions are vindicated – the survey reveals the extent to which financial professionals in the UK and US have witnessed negative consequences for whistleblowers firsthand:           
59% have seen whistleblowers subsequently left out of important decisions           33% have seen whistleblowers moved to a different team           32% have heard whistleblowers called derogatory names behind their backs or directly to their faceWhen asked what would encourage them to flag suspicious activity, 93% of workers surveyed would feel more comfortable doing so if they had more evidence, yet nearly half (48%) said the legal system simply does not adequately protect whistleblowers.
Jim Lucier, CEO at Medius, a leading global provider of cloud-based accounts payable automation and spend management solutions, said:
“White collar crime is on the rise and no organization is safe. Employees are the last line of defense against fraud but confidence to report suspicious activity is declining. AI anomaly-detection technology can provide employees with the evidence and assurances they need to be more forthcoming. Building a culture where employees feel comfortable to report their suspicions could save organizations millions in the long-run.”
Medius works with over 4,000 customers across 102 countries and processes $200 billion in annual spend. It uses the power of AI and automation to detect fraud the moment invoices are submitted safeguarding against bad actors and potential threats, internal and external.
Sherron Watkins, whistleblower who was called a “snitch”, said: “When someone is troubled by corporate wrongdoing and they attempt to sound the alarm, the pathway is uncharted, things happen organically. Normal rational people speak about their concerns with their closest friends and work colleagues, who often suggest staying safe saying “keep your head down, if you must report, go soft, nothing black and white.” Yet black and white evidence is what is needed to get the attention of those in power, either internally or with media or outside watchdog groups to prevent or stop fraudulent activity.”  
Jennifer Griffith, whistleblower who was called a “traitor”, said: “Choosing to blow the whistle involves more than just the desire to right a wrong.  It’s about protecting their employers from fraud. However, it’s more often than not seen as causing trouble for the employer, or as a self-serving action to get a financial reward. No one who chooses to blow the whistle expects to have their reputation attacked, their credibility impugned or to lose their job. The cost of ignoring a whistleblowers complaints are far greater than acknowledging that a problem exists and taking steps to fix it.  It’s been 19 years since I blew the whistle and the problems that existed then with the Social Security Administration still exist today. We must do more to protect whistleblowers.”
Sarah Carver, whistleblower who was called a “rat”, said: “The government’s attempt to conceal the fraud resulted in exacerbated damage, whereas a more prudent approach would have entailed immediate acknowledgement and rectification upon initial disclosure. The retaliatory measures aimed at silencing me made me stronger and fight harder to find someone to listen and stop the fraud.”
Georgina Hallford-Hall, CEO of Whistleblowers UK, said: “Too many organisations talk the talk but fail to engage with whistleblowers often at great cost to both. Technology used properly can remove the fear that both organisations and whistleblowers have about dealing with whistleblowing because it removes the person and focuses on the concerns or malfeasance. WhistleblowersUK are calling on the UK government to introduce an Independent Office of the Whistleblower to protect everyone from discrimination setting standards that end stigmatisation and discrimination making it safe to speak up.”
The billboard advertising campaign runs on Wall Street from Saturday, 18th May to Friday, 24th May 2024.
For more information about how Medius can prevent fraud, visit: https://www.medius.com/whistleblowing/
Notes to Editor
Methodology
The research was conducted by Censuswide with 1500 financial professionals in the UK and US (aged 18+) between 04/22/24 – 05/07/24. Censuswide abide by and employ members of the Market Research Society which is based on the ESOMAR principles and are members of The British Polling Council.
For more information, please contact: 
Fight or Flight for [email protected] / +44 330 133 0985
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/medius/r/snitch—traitor—rat–courageous-whistleblowers-reclaim-derogatory-terms-as-data-shows-80–of-fina,c3985054

View original content:https://www.prnewswire.co.uk/news-releases/courageous-whistleblowers-reclaim-derogatory-terms-as-data-shows-80-of-financial-professionals-stay-silent-on-suspected-internal-fraud-fearing-retaliation-302151622.html

Continue Reading

Artificial Intelligence

ThroughPut.AI and Inteligistics Announce Strategic Partnership to Transform Agriculture and Fresh Produce Supply Chains

Published

on

throughput.ai-and-inteligistics-announce-strategic-partnership-to-transform-agriculture-and-fresh-produce-supply-chains

The Partnership focuses on driving maximum optimization of both the supply chain and interwoven cold chain to improve sales, profit margins, output, safety, and traceability.
PALO ALTO, Calif., May 21, 2024 /PRNewswire/ — ThroughPut Inc., the industrial AI supply chain Decision Intelligence pioneer, and Inteligistics, the leading digital visibility solutions provider for perishable supply chains, today announced a strategic technology alliance to accelerate profitability for the sales of perishable goods. This area is typically plagued by volatile prices and volumes, poor predictions, limited supply chain visibility, and excessive product spoilage. This leads to high rejection and discount rates, and avoidable lost margins. ThroughPut.AI, in collaboration with Inteligistics, will enable growers, suppliers, carriers, distributors, and retailers to significantly improve the efficiency of their supply and cold chain operations, thus ensuring that all fresh products – ranging from berries and vegetables to fish and meat – is sold profitably on-time and in-full for faster, fresher and safer delivery with full supply chain visibility.

Mutual customers introduced ThroughPut.AI and Inteligistics as complementary partners due to ThroughPut.AI’s patented, Gartner-ranked comprehensive Supply Chain Analytics & Decision Intelligence software, with Inteligistics’ industry-leading expertise in supply chain performance, productivity, and sustainability, where both have yielded high-value outcomes for customers, their consumers, and owner-investors across the globe. The two companies also share a common goal of minimizing waste, shrink, unfilled orders, and lost sales.
“We’re delighted to partner with Inteligistics as we look to expand our capabilities for our clients in the critical Food and Agricultural industry. Food and AG supply chains suffer from siloed legacy point solutions that don’t address today’s supply chain networks’ complexity and volatility. To overcome these modern Food and AG supply chain challenges, already existing but disparate data must be tapped into, stitched together, analyzed, visualized, and optimized with Industrial-grade AI for actionable recommendations and better results,” explained Seth Page, COO and Head of Strategic Partnerships of ThroughPut Inc. “By partnering with Inteligistics, we can provide customers with our unprecedented supply chain visibility, actionability, predictions and recommendations into customers’ cold chain operations as part of their larger end-to-end supply chain networks. This allows customers to leverage data at every step of the way to make the right produce available at the right place, at the right time, to the right customer, at the best price, in the correct quantities, and in the safest traceable manner possible.”
“Our partnership with ThroughPut.AI will empower agricultural producers, and buyers to leverage data for timely, intelligent decision-making, while accelerating margins,” said Rao Mandava, CEO and Chairman at Inteligistics. “Our customers will now have a unified common operating picture for a single source of truth for all their perishable inventory, enabling them to reduce risk, increase safety, and unlock new growth opportunities. The data is also available for our recently unveiled 1-Click FSMA 204 Traceability reporting solutions. All our supply and cold chain solutions work with data from a company’s legacy data platforms, including ERP, WMS and procurement systems, eliminating the major operational disruption associated with platform replacement.”
Joint Capabilities
Bringing together ThroughPut’s patented and award-winning AI-powered Supply Chain Advanced Analytics and Decision Intelligence solution with Inteligistics’ innovative supply and cold chain performance improvement capabilities will empower their customers to drive additional value in many key areas including the following:
Fill Rate: The joint solution will provide customers with an innovative fill rate model that will enable them to:Dynamically allocate products when farm and producer outputs vary, thus ensuring timely demand fulfillment.Proactively forecast customer demand, pricing, and volumes, as well as leveraging advanced analytics to balance supply with demand on a real-time basis.Tailor fill-rates based on customer segmentation, helping customers to prioritize higher contribution margin product mixes with the best on-time and in-full (OTIF) rates to maximize returns.Scheduling: The combined solution will empower suppliers and buyers to optimize loading facility and cross-docking queuing, slotting, scheduling, loading and usage via:Data-driven recommendations for ideal order fulfillment time-slots based on customer segmentation, available inventory, and priority-based delivery of in-demand products across the supply chain.Ensure necessary labor, docks and slots are available for loading on time to further enhance operational efficiency, greater throughput, higher output, and additional revenue and profit generation.Streamline the scheduling process and maximize order fulfillment while minimizing delays, idle time, and site traffic.Rejection and Discount Rates: Leveraging data inputs from Inteligistics and ThroughPut.AI will deliver fresh Food & Agriculture specific capabilities, including:Actionable insights and recommendations to optimize end-to-end supply chain operations while maintaining traceable product quality and food safety, for a greater bottom-line with enhanced regulatory compliance.Minimize rejection factors by analyzing data on product temperatures, sales history, and movements across supply chain networks to predict the likelihood of rejection or discounts, while reducing rejection rates and discounts in shipments that are fully traceable and quantifiable.Minimize waste and discounts to consumers by managing the inventory from DCs to stores using predictive shelf life and First Expire/First Out distribution.PR Contact
Tina Jacobs
[email protected]
About ThroughPut:
ThroughPut.AI is a Silicon Valley-based Supply Chain AI leader that puts Industrial material flows on Autopilot by leveraging existing Enterprise Data to achieve superior Business, Operations, Financial and Sustainability Results. ThroughPut.AI’s patented, Gartner-recognized AI-powered Supply Chain Analytics and Decision Intelligence software platform predicts Demand, reorients Production Capacity, reassigns Warehouse Space, and reorders Materials optimally, so businesses minimize overpromising and under-delivering, and maximize for their desired outcomes. As a rapid diagnostic platform, ThroughPut.AI both improves material flow and free-cash-flow across the entire end-to-end value chain far faster than leading contemporary and legacy solutions could ever imagine. The founding team is led by seasoned serial entrepreneurs with real-world AI, Supply Chain, Manufacturing, Transportation and Operations experience, from the shopfloor to the top-floor, at leading Fortune 500 Industrial Companies & pioneering Enterprise Technology companies that have impacted the world.
To learn more about ThroughPut Inc, visit our website today.
Additional Resources:
Learn more about ThroughPut Food and Beverage Solution OfferingsFor more information about ThroughPut, visit ThroughPut Resource LibraryRead the ThroughPut Blog and access latest ThroughPut Press CoverageAbout Inteligistics: 
Inteligistics is uniquely placed in perishables industries using Silicon Valley technology and process improvements to bring digital transformation, turn Big Data into clear actions through AI/ML, and deliver high value improvements to supply chain and cold chain performance for perishable commodities. The resulting increase in productivity and reduction in critical cut-to-cool times, resources help meet sustainability goals. Using IoT, off-the-shelf wireless hardware, and proprietary cloud-based applications, Inteligistics develops custom solutions and provides an end-to-end integrated supply chain platform and standalone applications that improve quality, throughput, increase profits and deliver high ROI on the critical process of moving product from field to consumer. Visit inteligistics.com and linkedin.com/company/inteligistics.

View original content:https://www.prnewswire.co.uk/news-releases/throughputai-and-inteligistics-announce-strategic-partnership-to-transform-agriculture-and-fresh-produce-supply-chains-302151475.html

Continue Reading

Artificial Intelligence

Lukka Acquires Coinfirm bringing Audited Data to Blockchain Analytics, Compliance, and Investigations

Published

on

lukka-acquires-coinfirm-bringing-audited-data-to-blockchain-analytics,-compliance,-and-investigations

NEW YORK, May 21, 2024 /PRNewswire/ — Lukka, the global leader in enterprise digital asset data and software solutions, proudly announces its acquisition of Coinfirm, a top-tier European based blockchain analytics software company. This acquisition deepens Lukka’s existing capabilities to now support a comprehensive set of on-chain analytics of compliance, AML, sanction screening, entity due diligence, and investigations business needs. The new combined offering utilizes the industry’s only audited, institutional grade datasets at a time when trust in the quality and accuracy of data has become essential.

Since 2016, Coinfirm has been at the forefront of digital asset transaction analysis and monitoring, specializing in compliance, AML (Anti-Money Laundering) detection, and advanced blockchain analytics. Lukka’s enterprise focused approach integrates Coinfirm blockchain data into its platforms with conventional financial information, and maintains existing trusted standards in the form of an AICPA SOC Operational risk controls. Coinfirm was a natural addition to Lukka’s existing product suite due to their prior adherence to AICPA SOC 2 standards, audited by a Big 4 accounting firm. 
“Our customers have stated very clearly that they want data that they can trust and that they have too many overlapping vendors, which creates inefficiency and unnecessary spending. We spent years of due diligence across hundreds of businesses and customer feedback discussions and very carefully selected Coinfirm.
Ultimately, the decision was easy – the team that they have built is incredibly talented and their data quality is best in class. At Lukka we know data and the data behind their on-chain analytics and investigative products was the most comprehensive and highest quality. Lukka is a single provider for all of your crypto data needs.”    said Robert Materazzi, CEO at Lukka.
The integration of the Coinfirm team and products with Lukka is not just an expansion of services but a strategic move towards offering an unmatched range of on-chain and off-chain data solutions.  In addition to Lukka’s commercial strategy, the story doesn’t end with this acquisition. Lukka is continuously assessing opportunities to partner and work with great teams across the world.
About Lukka
Founded in 2014, Lukka serves the most risk-mature businesses in the world with institutional data and software solutions. As a global company, headquartered in the United States, Lukka bridges the gap between the complexities of blockchain data in a global crypto ecosystem with traditional business and reporting requirements.
All of Lukka’s products are created with institutional standards, such as AICPA Service and Organization Controls (SOC), which focus on data quality, financial calculation accuracy & completeness, and managing technology operational risk. Lukka has obtained AICPA SOC 1 Type II and SOC 2 Type II Audits, an ISO/IEC-27001 certification, NIST Cybersecurity Assessment, and continues to lead the industry with best in class technology risk governance.
Our global team looks forward to partnering with you to solve your data challenges.
For information about Lukka, visit lukka.tech.
Media Contact:Rafal [email protected] 
Logo – https://mma.prnewswire.com/media/2003376/Logo_Blue_2x_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/lukka-acquires-coinfirm-bringing-audited-data-to-blockchain-analytics-compliance-and-investigations-302151608.html

Continue Reading
Advertisement
Advertisement

Latest News

Trending